Healthcare and life sciences
Rising stars
Rising stars with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Goldfarb Gross Seligman & Co.
Associate, Life Sciences, Hi-Tech and Venture Capital, M&A
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Leading individuals
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
M. Firon & Co Advocates and Notaries
Baruch Shugol is a partner at M. Firon & Co. Baruch is one of the most seasoned, outstanding and valued attorneys in the biotech and pharmaceutical fields in Israel, and a trusted legal advisor to large-cap corporations in Israel and abroad. Over the span of the past four decades he has handled vital commercial issues in the pharmaceutical domain, some of which are considered major milestones in the global pharmaceutical industry. Baruch’s legal work encompasses all the commercial, scientific and legal elements involved in the pharmaceutical field. One of many testimonies to his work capacity is his close involvement and counsel in the Smith Kline Beecham merger with Glaxo Wellcome, one of the largest mergers in pharmaceutical history, which conceived the biggest pharmaceutical company in the world at that time. Baruch’s knowledge and proficiency span across all the commercial aspects required for the operations of pharmaceutical companies, starting with research and development, through commercial agreements and antitrust, to litigation and representation in court. Aside from providing comprehensive legal services to some of the largest and most prominent pharmaceutical companies in the world, Baruch is widely known for his strategic activity in this industry, utilizing his long-standing professional experience. Demonstrating this ability is his membership of the Tel Aviv Sourasky Medical Center Institutional Review Board (Helsinki Committee), which is responsible for clinical trials and has an overall crucial impact on the future of the pharmaceutical market. In addition, he serves as the legal counsel for "Pharma Israel", an umbrella organization of pharmaceutical source companies in Israel, which incorporates dozens of Israeli and international pharmaceutical enterprises. Furthermore, Baruch formerly served in a number of senior managerial positions in various pharmaceutical companies, including Marketing Manager of Teva’s Pharmaceutical Division. On top of Baruch’s activities in the pharmaceutical domain, he is an expert in the field of biotech, having represented a wide range of biotech companies in their local and overseas operations. Moreover, he is a leading attorney in the areas of receivership, liquidation, litigation and arbitration and over the years has been actively involved in complex proceedings thereof, representing a myriad of companies and institutions, including some of Israel’s largest banks.
FISCHER (FBC & Co.)
FBC - Raz Tepper Mr. Tepper is a partner in the firm’s Corporate Department, with a diverse corporate practice, encompassing mergers and acquisitions, securities law, corporate finance, and general corporate matters. He has represented public and private acquirers and target companies, and private equity firms and investment banks in a variety of domestic and cross-border mergers and acquisitions transactions, divestitures, joint ventures, restructurings, and other corporate matters. Mr. Tepper provides day-to-day counseling to the firm's technology clients with a particular focus on life science and medical service providers, playing a key role in advising clients in all stages of their development, from start-up through to public offering. Mr. Tepper has been involved in the establishment and representation of private investment and private equity funds. Mr. Tepper has an active practice representing international clients in their business activities in Israel.
Horn & Co